FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311527900> ?p ?o ?g. }

• W4311527900 endingPage "2720" @default.
• W4311527900 startingPage "2720" @default.
• W4311527900 abstract "Torsemide is a widely used diuretic in clinical practice. In this study, pharmacokinetic (PK) and pharmacodynamic (PD) simulations of torsemide for various population groups and exposure scenarios were performed through human-scale physiologically-based PK-PD (PBPK-PD) modeling of torsemide. For PBPK-PD modeling of torsemide, invitro and clinical data of torsemide reported previously were used. After exposure to clinical doses of torsemide, observed plasma (or serum) concentration and urine torsemide excretion profiles were used as PK-data, and observed urinary sodium excretion rate was used as PD-data. The model was then extended to take into account physiological and biochemical factors according to different CYP2C9 phenotypes or patient populations. The established model captured various torsemide clinical results well. Differences in torsemide PKs and PDs between patient groups or CYP2C9 genetic polymorphisms were modelologically identified. It was confirmed that degrees of differences in torsemide PKs and PDs by disease groups were greater than those according to different CYP2C9 phenotypes. According to torsemide administration frequency or dose change, it was confirmed that although the difference in plasma PKs between groups (healthy adult and patient groups) could increase to 14.80 times, the difference in PDs was reduced to 1.01 times. Results of this study suggested that it is very important to consider disease groups in the setting of torsemide clinical therapy and that it is difficult to predict PD proportionally with only differences in PKs of torsemide between population groups. The PBPK-PD model established in this study is expected to be utilized for various clinical cases involving torsemide application in the future, enabling optimal drug therapy." @default.
• W4311527900 created "2022-12-26" @default.
• W4311527900 creator A5014972082 @default.
• W4311527900 creator A5063915727 @default.
• W4311527900 creator A5067194755 @default.
• W4311527900 date "2022-12-05" @default.
• W4311527900 modified "2023-10-14" @default.
• W4311527900 title "Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling" @default.
• W4311527900 cites W1497544956 @default.
• W4311527900 cites W152943885 @default.
• W4311527900 cites W1720848645 @default.
• W4311527900 cites W1852552079 @default.
• W4311527900 cites W1967221084 @default.
• W4311527900 cites W1968316922 @default.
• W4311527900 cites W1968468567 @default.
• W4311527900 cites W1975272082 @default.
• W4311527900 cites W1984361968 @default.
• W4311527900 cites W1984909365 @default.
• W4311527900 cites W1990603922 @default.
• W4311527900 cites W1992857605 @default.
• W4311527900 cites W1993845357 @default.
• W4311527900 cites W1998523124 @default.
• W4311527900 cites W2007274583 @default.
• W4311527900 cites W2015838352 @default.
• W4311527900 cites W2016351075 @default.
• W4311527900 cites W2020621418 @default.
• W4311527900 cites W2045867444 @default.
• W4311527900 cites W2047234939 @default.
• W4311527900 cites W2048397943 @default.
• W4311527900 cites W2061729745 @default.
• W4311527900 cites W2062122879 @default.
• W4311527900 cites W2065719111 @default.
• W4311527900 cites W2077386711 @default.
• W4311527900 cites W2089886566 @default.
• W4311527900 cites W2090361509 @default.
• W4311527900 cites W2095810566 @default.
• W4311527900 cites W2099063290 @default.
• W4311527900 cites W2100037820 @default.
• W4311527900 cites W2107919217 @default.
• W4311527900 cites W2115314508 @default.
• W4311527900 cites W2117771590 @default.
• W4311527900 cites W2122698580 @default.
• W4311527900 cites W2149393466 @default.
• W4311527900 cites W2154694410 @default.
• W4311527900 cites W2159248641 @default.
• W4311527900 cites W2211785730 @default.
• W4311527900 cites W2330324570 @default.
• W4311527900 cites W2431622064 @default.
• W4311527900 cites W2522795135 @default.
• W4311527900 cites W256677 @default.
• W4311527900 cites W2738697628 @default.
• W4311527900 cites W2764134599 @default.
• W4311527900 cites W2792423652 @default.
• W4311527900 cites W2886788587 @default.
• W4311527900 cites W2955449238 @default.
• W4311527900 cites W2978737563 @default.
• W4311527900 cites W3009599503 @default.
• W4311527900 cites W3017046006 @default.
• W4311527900 cites W3137921680 @default.
• W4311527900 cites W3157391757 @default.
• W4311527900 cites W3165429299 @default.
• W4311527900 cites W3186879637 @default.
• W4311527900 cites W3215587297 @default.
• W4311527900 cites W402335930 @default.
• W4311527900 cites W4211025575 @default.
• W4311527900 cites W4224325771 @default.
• W4311527900 cites W73001605 @default.
• W4311527900 cites W924770963 @default.
• W4311527900 doi "https://doi.org/10.3390/pharmaceutics14122720" @default.
• W4311527900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36559213" @default.
• W4311527900 hasPublicationYear "2022" @default.
• W4311527900 type Work @default.
• W4311527900 citedByCount "1" @default.
• W4311527900 countsByYear W43115279002023 @default.
• W4311527900 crossrefType "journal-article" @default.
• W4311527900 hasAuthorship W4311527900A5014972082 @default.
• W4311527900 hasAuthorship W4311527900A5063915727 @default.
• W4311527900 hasAuthorship W4311527900A5067194755 @default.
• W4311527900 hasBestOaLocation W43115279001 @default.
• W4311527900 hasConcept C111113717 @default.
• W4311527900 hasConcept C112705442 @default.
• W4311527900 hasConcept C126322002 @default.
• W4311527900 hasConcept C185867374 @default.
• W4311527900 hasConcept C2908647359 @default.
• W4311527900 hasConcept C3946865 @default.
• W4311527900 hasConcept C526171541 @default.
• W4311527900 hasConcept C62231903 @default.
• W4311527900 hasConcept C71924100 @default.
• W4311527900 hasConcept C98274493 @default.
• W4311527900 hasConcept C99454951 @default.
• W4311527900 hasConceptScore W4311527900C111113717 @default.
• W4311527900 hasConceptScore W4311527900C112705442 @default.
• W4311527900 hasConceptScore W4311527900C126322002 @default.
• W4311527900 hasConceptScore W4311527900C185867374 @default.
• W4311527900 hasConceptScore W4311527900C2908647359 @default.
• W4311527900 hasConceptScore W4311527900C3946865 @default.
• W4311527900 hasConceptScore W4311527900C526171541 @default.
• W4311527900 hasConceptScore W4311527900C62231903 @default.

• next